• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

Novartis' Sandoz dips on debut after lower than expected valuation

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Oct 04, 2023 at 09:52: AM
via
  • Sandoz valued at 10.3 bln francs on market debut
  • Shares dip following debut at 24 francs apiece
  • Fragile stock markets make for difficult backdrop

article source
 




Top Bottom
Back
Quote